全球止血市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球止血市場預計將從2025年的24.5億美元成長至2034年的42.1億美元，2026年至2034年的複合年成長率（CAGR）為6.21%。該市場正經歷顯著成長，主要原因是外科手術、創傷和慢性疾病的日益增多，這些疾病都需要有效的止血管理。醫療專業人員正在採用先進的止血產品來改善患者預後、減少手術併發症並縮短復原時間。不斷成長的醫療保健支出和醫療技術的持續進步正在推動醫院和手術中心對創新止血解決方案的需求不斷成長。

心血管手術、整形外科手術和微創手術數量的不斷成長，推動了全球相關產品的應用。製造商正將先進的止血劑、密封劑和生物來源產品推向市場，這些產品能夠實現更快的止血效果並提升臨床療效。醫療基礎設施投資的增加以及現代外科手術服務的普及，也為該行業的企業創造了更多機會。

技術創新不斷提升產品的安全性、有效性和易用性，進而帶來持續積極的市場前景。對先進外科手術需求的不斷成長、人口老化以及對病患​​安全日益成長的關注，都將支撐市場的長期成長。再生醫學和生物工程止血材料的持續研究有望催生新一代產品，進一步推動產業擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：我們全面檢驗主要地理區域的市場表現，識別高成長領域和區域趨勢，並深入了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球止血市場：依產品類型分類

• 市場分析、洞察與預測
• 局部止血劑（膠原蛋白、ORC、明膠、多醣）
• 注射用止血劑（新鮮冷凍血漿、血小板濃縮液、凝血因子VIII、凝血酶原複合物）
• 高級止血劑（液體、凝血酶、纖維蛋白、合成）

第5章：全球止血劑市場：以劑型分類

• 市場分析、洞察與預測
• 基質和凝膠
• 海綿墊
• 粉末
• 液體/噴霧

第6章：全球止血市場：依應用分類

• 市場分析、洞察與預測
• 創傷
• 外科手術
• 血友病
• 心肌梗塞
• 血栓症
• 其他

第7章：全球止血市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所及門診手術中心
• 其他

第8章 全球止血市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CSL Behring
  • Grifols SA
  • Johnson & Johnson（Ethicon）
  • Tricol Biomedical
  • CryoLife Inc.（Artivion）
  • Integra LifeSciences Holdings Corporation
  • Marine Polymer Technologies Inc
  • KitoTech Medical
  • Arch Biomedical

The global hemostasis market size is expected to reach USD 4.21 Billion in 2034 from USD 2.45 Billion in 2025, growing at a CAGR of 6.21 during 2026-2034.This market is witnessing significant growth due to the increasing prevalence of surgical procedures, traumatic injuries, and chronic medical conditions requiring effective bleeding management. Healthcare providers are adopting advanced hemostatic products to improve patient outcomes, reduce surgical complications, and shorten recovery periods. Rising healthcare expenditure and continuous improvements in medical technologies are supporting the growing demand for innovative hemostasis solutions across hospitals and surgical centers.

Growing numbers of cardiovascular surgeries, orthopedic procedures, and minimally invasive operations are driving product adoption worldwide. Manufacturers are introducing advanced hemostatic agents, sealants, and biologically derived products that provide faster bleeding control and improved clinical performance. Increasing investments in healthcare infrastructure and expanding access to modern surgical care are creating additional opportunities for companies operating within this industry.

The future outlook remains favorable as technological innovation continues improving product safety, effectiveness, and ease of use. Rising demand for advanced surgical procedures, expanding aging populations, and increasing focus on patient safety will sustain long-term market growth. Ongoing research in regenerative medicine and bioengineered hemostatic materials is expected to introduce next-generation products that further strengthen industry expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Topical Hemostasis (Collagen, ORC, Gelatin, Polysaccharides)
• Infusible Hemostasis (FFP, Platelet Conc, Factor VIII, PCC)
• Advanced Hemostasis (Flowable, Thrombin, Fibrin, Synthetic)

By Formulation

• Matrix & Gel
• Sponge & Pad
• Powder
• Liquid / Spray

By Application

• Trauma
• Surgery
• Hemophilia
• Myocardial Infarction
• Thrombosis
• Others

By End User

• Hospitals
• Clinics & ASCs
• Others

COMPANIES PROFILED

• CSL Behring, Grifols S.A., Johnson & Johnson (Ethicon), Tricol Biomedical, CryoLife Inc. (Artivion), Integra LifeSciences Holdings Corporation, Marine Polymer Technologies Inc., KitoTech Medical, Arch Biomedical

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Topical Hemostasis (Collagen, ORC, Gelatin, Polysaccharides) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infusible Hemostasis (FFP, Platelet Conc, Factor VIII, PCC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Advanced Hemostasis (Flowable, Thrombin, Fibrin, Synthetic) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS MARKET: BY FORMULATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Formulation
• 5.2. Matrix & Gel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sponge & Pad Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Liquid / Spray Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Trauma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hemophilia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Myocardial Infarction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Thrombosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinics & ASCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTASIS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Formulation
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Formulation
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Formulation
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Formulation
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Formulation
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTASIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CSL Behring
  • 10.2.2 Grifols S.A
  • 10.2.3 Johnson & Johnson (Ethicon)
  • 10.2.4 Tricol Biomedical
  • 10.2.5 CryoLife Inc. (Artivion)
  • 10.2.6 Integra LifeSciences Holdings Corporation
  • 10.2.7 Marine Polymer Technologies Inc
  • 10.2.8 KitoTech Medical
  • 10.2.9 Arch Biomedical